Naumann M, Kretschmer S, Dorst J, Lapp H, Peikert K, Petri S, Gess B, Wolf C, Rödiger A, Smesny U, Pan-Montojo F, Kerschen P, Grehl T, Prudlo J, Regensburger M, Ludolph A, Günther R, Brenner D, Lee-Kirsch MA, Hermann A (2026)
Publication Type: Journal article
Publication year: 2026
DOI: 10.1080/21678421.2026.2663910
Stimulation of the innate immune system has been implicated in ALS and particularly in distinct monogenic forms of ALS. To address whether this is of diagnostic value, we performed a proof-of concept study using qPCR to assess the Interferon score in blood samples of genetic ALS. 56.5% of genetic ALS patients showed significant IFN activation, highest in C9orf72HRE patients (77.3%). About half of FUS-ALS (52.2%), but none of SOD1-ALS patients demonstrated pathological IFN scores. The IFN score significantly correlated with the ALSFRS-R slope and inversely with the time to severe event as a survival surrogate in this genetic ALS cohort. IFN + patients were more likely to be male, showed more rapid disease progression and higher neurofilament levels. The IFN score might have the potential as a stratification and readout tool for biomarker-guided individualized therapy in ALS.
APA:
Naumann, M., Kretschmer, S., Dorst, J., Lapp, H., Peikert, K., Petri, S.,... Hermann, A. (2026). Innate immune signaling as a potential pathomechanistic biomarker for distinct subtypes in amyotrophic lateral sclerosis. . https://doi.org/10.1080/21678421.2026.2663910
MLA:
Naumann, Marcel, et al. "Innate immune signaling as a potential pathomechanistic biomarker for distinct subtypes in amyotrophic lateral sclerosis." (2026).
BibTeX: Download